BioNTech 2. Apr. 2026 Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Reuters Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Reuters Original